drugset / Trial / NCT00559299
Patient Tolerability Study of GSK163090
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability of a new drug, GSK163090, which is being developed for the treatment of depression and anxiety disorders.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK163090 | Small molecule | — | — |